Amelanotic Melanoma Presenting with Plasmacytoid Morphology and BRAF V600 Mutation.

Rare Tumors

Department of Pathology and Molecular Medicine, McMaster University, Hamilton, ON, Canada.

Published: May 2015

Plasmacytoid melanoma is an unusual variant of malignant melanoma. The plasmacytoid morphology can be found in a variety of other malignancies including carcinomas, plasma cell neoplasms, lymphoproliferative disorders, and sarcomas. The authors report a rare case of plasmacytoid amelanotic malignant melanoma in a 78-year-old man presenting with an enlarging palpable, erythematous mass on his left posterior shoulder. A fine needle aspirate showed atypical findings with single amelanotic cells with high nuclear to cytoplasmic ratio, mono- and multi-nucleation with prominent nucleoli and intranuclear inclusions. Review of the excision and immunohistochemical analysis revealed the malignant plasmacytoid cells stained with vimentin, S-100, HMB-45, and other staining patterns consistent with melanoma. Initial evaluation was negative for other sites of disease. However, 4 months later, the patient was noted to have metastatic disease to his lungs and liver. Given that the tumor was noted to be BRAF V600R mutated, the patient was started on single agent dabrafenib. The plasmacytoid morphology can be found in a variety of malignancies. Melanoma should be considered in the differential diagnosis of any malignancy presenting with plasmacytoid features.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4508639PMC
http://dx.doi.org/10.4081/rt.2015.5698DOI Listing

Publication Analysis

Top Keywords

plasmacytoid morphology
12
presenting plasmacytoid
8
malignant melanoma
8
morphology variety
8
variety malignancies
8
plasmacytoid
7
melanoma
5
amelanotic melanoma
4
melanoma presenting
4
morphology braf
4

Similar Publications

How do immune cells shape type 1 diabetes? Insights from Mendelian randomization.

Front Endocrinol (Lausanne)

January 2025

School of Traditional Chinese Medicine, Hunan University of Chinese Medicine, Changsha, Hunan, China.

Objective: The role of immune cells in type 1 diabetes (T1D) is unclear. The aim of this study was to assess the causal effect of different immune cells on T1D using Mendelian randomization (MR).

Methods: A dataset of immune cell phenotypes (numbered from GCST0001391 to GCST0002121) was obtained from the European Bioinformatics Institute, while a T1D dataset (numbered finngen_R10_T1D) was obtained from FinnGen.

View Article and Find Full Text PDF

Research Progress in Blastic Plasmacytoid Dendritic Cell Neoplasm.

Zhongguo Yi Xue Ke Xue Yuan Xue Bao

December 2024

Department of Hematology, Hebei General Hospital,Shijiazhuang 050051,China.

Blastic plasmacytoid dendritic cell neoplasm(BPDCN)is an extremely rare invasive tumor with poor prognosis.The common clinical manifestations of BPDCN include skin injury,bone marrow involvement,and tumor cell spread.BPDCN is often misdiagnosed as other diseases and its diagnosis often requires a combination of clinical manifestations,imaging,histology,and immunophenotyping.

View Article and Find Full Text PDF

[Clinical and Pathological Features of Blastic Plasmacytoid Dendritic Cell Neoplasm].

Zhongguo Shi Yan Xue Ye Xue Za Zhi

December 2024

Department of Laboratory Medicine, West China Hospital, Sichuan University, Chengdu 610041, Sichuan Province, China.

Objective: To summarize and analyze the clinical features of blastic plasmacytoid dendritic cell neoplasm (BPDCN), so as to enhance the understanding of this disease.

Methods: The clinical manifestations, immunophenotype, pathological features, treatment and prognosis of 11 cases of BPDCN were retrospectively analyzed.

Results: Among the 11 patients diagnosed with BPDCN, there were 8 males and 3 females, with a median age of 44 (6-81) years.

View Article and Find Full Text PDF

Background/aim: Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare and highly aggressive hematologic cancer which is difficult to diagnose and has a lot of overlapping features with other diseases, particularly acute myeloid leukemia (AML). BPDCN shares several immunophenotypic markers with AML, such as CD4, CD56, CD123, and HLA-DR, stating the importance of having extending panel of specific immunohistochemical (IHC) markers.

Case Report: This report details a case of CLL who presented with worsening symptoms of recurrent infections and leukocytosis.

View Article and Find Full Text PDF

Introduction: We aimed to identify additional predictors of severe fever with thrombocytopenia syndrome (SFTS), which has a significantly increasing global incidence.

Methods: This retrospective study included 95 patients with SFTS and 30 healthy individuals. Complete blood count with differential was performed using Sysmex XN 9000 and Mindray BC-6800 Plus analyzers.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!